- Home
- MVIS vs TNGX Comparison
MVIS vs TNGX Comparison
Compare MVIS & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MVIS
- TNGX
- Stock Information
- Founded
- MVIS 1993
- TNGX 2014
- Country
- MVIS United States
- TNGX United States
- Employees
- MVIS N/A
- TNGX N/A
- Industry
- MVIS Industrial Machinery/Components
- TNGX Biotechnology: Pharmaceutical Preparations
- Sector
- MVIS Technology
- TNGX Health Care
- Exchange
- MVIS Nasdaq
- TNGX Nasdaq
- Market Cap
- MVIS 308.8M
- TNGX 317.4M
- IPO Year
- MVIS 1996
- TNGX N/A
- Fundamental
- Price
- MVIS $1.48
- TNGX $1.76
- Analyst Decision
- MVIS Buy
- TNGX Strong Buy
- Analyst Count
- MVIS 4
- TNGX 7
- Target Price
- MVIS $2.67
- TNGX $12.33
- AVG Volume (30 Days)
- MVIS 7.5M
- TNGX 801.9K
- Earning Date
- MVIS 05-08-2025
- TNGX 05-07-2025
- Dividend Yield
- MVIS N/A
- TNGX N/A
- EPS Growth
- MVIS N/A
- TNGX N/A
- EPS
- MVIS N/A
- TNGX N/A
- Revenue
- MVIS $8,147,000.00
- TNGX $42,069,000.00
- Revenue This Year
- MVIS N/A
- TNGX N/A
- Revenue Next Year
- MVIS $330.45
- TNGX N/A
- P/E Ratio
- MVIS N/A
- TNGX N/A
- Revenue Growth
- MVIS 277.53
- TNGX 15.17
- 52 Week Low
- MVIS $0.80
- TNGX $1.71
- 52 Week High
- MVIS $1.95
- TNGX $12.02
- Technical
- Relative Strength Index (RSI)
- MVIS 57.54
- TNGX 33.97
- Support Level
- MVIS $1.23
- TNGX $1.80
- Resistance Level
- MVIS $1.40
- TNGX $2.04
- Average True Range (ATR)
- MVIS 0.12
- TNGX 0.18
- MACD
- MVIS 0.03
- TNGX 0.01
- Stochastic Oscillator
- MVIS 94.23
- TNGX 20.19
About MVIS MicroVision Inc.
Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.